Steven Gelone
2019
In 2019, Steven Gelone earned a total compensation of $1.2M as President and Chief Operating Officer at Nabriva Therapeutics AG, a 12% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $181,420 |
|---|---|
| Option Awards | $309,859 |
| Salary | $472,100 |
| Stock Awards | $200,925 |
| Other | $13,976 |
| Total | $1,178,280 |
Gelone received $472.1K in salary, accounting for 40% of the total pay in 2019.
Gelone also received $181.4K in non-equity incentive plan, $309.9K in option awards, $200.9K in stock awards and $14K in other compensation.
Rankings
In 2019, Steven Gelone's compensation ranked 8,515th out of 13,971 executives tracked by ExecPay. In other words, Gelone earned more than 39.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,515 out of 13,971 | 39th |
Division Manufacturing | 3,373 out of 5,695 | 41st |
Major group Chemicals And Allied Products | 1,277 out of 2,194 | 42nd |
Industry group Drugs | 1,086 out of 1,880 | 42nd |
Industry Pharmaceutical Preparations | 806 out of 1,392 | 42nd |
Source: SEC filing on June 25, 2020.
Gelone's colleagues
We found two more compensation records of executives who worked with Steven Gelone at Nabriva Therapeutics AG in 2019.